DG Capital Management
BSX icon

DG Capital Management’s Boston Scientific BSX Stock Holding History

DG Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-300,000
Closed -$12.8M – 34
2026
Q2 		$12.8M Buy
+300,000
New +$16.3M 2.7% 13
2021
Q1 		– Sell
-115,620
Closed -$4.16M – 127
2020
Q4 		$4.16M Buy
+115,620
New +$4.17M 1.76% 22

Other funds holding BSX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

DG Capital Management's BSX Position: Q3 2026 in Review

DG Capital Management sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 300,000 shares — an estimated $12.8M sold.

DG Capital Management first reported a position in BSX in Q4 2020 and held it in 2 quarters. The position peaked at $12.8M in Q2 2026. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • DG Capital Management reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • DG Capital Management sold 300,000 Boston Scientific shares in Q3 2026, an estimated $12.8M.
  • DG Capital Management first reported a position in Boston Scientific in Q4 2020 and held it in 2 quarters.
  • DG Capital Management's Boston Scientific position peaked at $12.8M in Q2 2026.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on DG Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.